Paper Details 
Original Abstract of the Article :
In conclusion, many drugs have been used as lipid lowering agents. Only five currently combine efficacy and acceptable side effects. None of these, nicotinic acid, clofibrate, probucol, cholestyramine or colestipol, is without serious drawbacks. In using lipid lowering drugs, it is important to bear...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1177/000331978203300902

データ提供:米国国立医学図書館(NLM)

The Shifting Sands of Lipid-Lowering Drugs: A Desert of Challenges

The field of cardiovascular health is a vast and challenging desert, with researchers constantly seeking new and effective ways to combat high cholesterol levels. This study, like a camel caravan traversing a landscape of lipid-lowering drugs, explores the challenges and limitations of existing treatments. The researchers, like experienced explorers, analyze the mechanisms of action and potential drawbacks of various lipid-lowering drugs, providing a comprehensive overview of the current therapeutic landscape.

The Desert of Cholesterol: A Search for Effective and Safe Treatments

The study highlights the limitations of existing lipid-lowering drugs, emphasizing the need for ongoing research and development of new and more effective therapies. The researchers, like explorers searching for a hidden oasis, acknowledge the challenges of finding safe and effective treatments while minimizing side effects. This study underscores the importance of continued innovation in this field, offering a call to action for researchers to navigate the shifting sands of lipid-lowering therapies.

Navigating the Desert: Choosing the Right Path for Lipid Management

This study provides valuable insights for patients and clinicians navigating the desert of lipid management. It emphasizes the importance of individualized treatment plans, considering the specific needs and risks of each patient. Imagine a desert landscape with multiple paths leading to different destinations. This study helps us understand the unique characteristics of each path, allowing us to make informed decisions and choose the most effective and safe route for managing cholesterol levels.

Dr.Camel's Conclusion

This study, like a guidebook through the desert of lipid-lowering drugs, reveals the challenges and limitations of existing therapies. It emphasizes the need for ongoing research and development of new and safer treatments. As we continue to explore the vast expanse of cardiovascular health, this study serves as a valuable guidepost in our quest for better and more effective lipid management strategies.

Date :
  1. Date Completed 1982-12-02
  2. Date Revised 2017-02-14
Further Info :

Pubmed ID

7125296

DOI: Digital Object Identifier

10.1177/000331978203300902

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.